In patients with a documented penicillin allergy, cephalosporins with dissimilar side chains are generally considered safer because of lower cross-reactivity.

• A. True
• B. False
• C. Only in skin testing
• D. Not studied

Answer: (A)

The important idea is that cross-reactivity between penicillins and cephalosporins depends on how similar the cephalosporin’s R1 side chain is to the penicillin’s side chain. When the cephalosporin has a side chain that is different from penicillin’s, the immune system is much less likely to recognize it as the same allergen, so the risk of an IgE-mediated reaction is very low. Because of this, cephalosporins with dissimilar side chains are generally considered safer for patients with a documented penicillin allergy. Modern data place this cross-reactivity at roughly 1% or lower for dissimilar side chains, much less than the historical estimates that led to blanket avoidance. Skin testing can be helpful in uncertain cases or with severe prior reactions, but it isn’t required to justify using a cephalosporin with a dissimilar side chain. If the cephalosporin’s side chain is similar to penicillin’s, the risk is higher and clinicians may avoid it or proceed with extra caution. So, the statement is true.